Rigas, James
AstraZeneca,
United States
2024 Rank: 155778
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Respiratory System
Rank in SubField 1: 5841 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 155778 | 175306 |
| Total Cites | 8005 | 8556 |
| H-index | 39 | 40 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 125 | 128 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 402 | 415 |
| Number of Single+First+Last Authored Papers | 40 | 40 |
| Total Cites to Single+First+Last Authored Papers | 1108 | 1125 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7244 | 7664 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.12 |
| Self-Citation Percentage |
6.44%
|
|
Rigas, James
MedImmune, Inc.,
United States
2023 Rank: 148499
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Respiratory System
Rank in SubField 1: 5640 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 148499 | 166722 |
| Total Cites | 7719 | 8260 |
| H-index | 38 | 39 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 123 | 126 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 395 | 408 |
| Number of Single+First+Last Authored Papers | 40 | 40 |
| Total Cites to Single+First+Last Authored Papers | 1066 | 1083 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6972 | 7384 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.12 |
| Self-Citation Percentage |
6.55%
|
|
Rigas, James
AstraZeneca,
United States
2022 Rank: 140350
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Respiratory System
Rank in SubField 1: 5329 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 140350 | 152688 |
| Total Cites | 7337 | 7862 |
| H-index | 37 | 39 |
| Hm-index | 12 | 13 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 120 | 123 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 387 | 400 |
| Number of Single+First+Last Authored Papers | 40 | 40 |
| Total Cites to Single+First+Last Authored Papers | 1021 | 1038 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6615 | 7013 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.12 |
| Self-Citation Percentage |
6.68%
|
|
Rigas, James
AstraZeneca,
United States
2021 Rank: 134694
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Respiratory System
Rank in SubField 1: 5148 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 134694 | 149688 |
| Total Cites | 7104 | 7619 |
| H-index | 37 | 39 |
| Hm-index | 12 | 13 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 120 | 123 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 379 | 392 |
| Number of Single+First+Last Authored Papers | 39 | 39 |
| Total Cites to Single+First+Last Authored Papers | 986 | 1003 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6396 | 6784 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.12 |
| Self-Citation Percentage |
6.76%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.